Sorted By:


Seniors Rate Part D Highly on Many Measures

Chartpack  |  From Our Network

Medicare Part D beneficiaries report that their plans are affordable and work well....

VA Formulary Covers Fewer Drugs Than Part D

Chartpack  |  From Our Network

For 2015, the VA formulary included a lower share of the top 200 Part D drugs relative to stand-alone Prescription Drug Plans and Medicare Advantage Prescription Drug Plans....

Part D Implementation Improved Enrollees’ Access to Medicine and Reduced Out-of-Pocket Costs

Chartpack  |  From Our Network

Peer-reviewed and academic literature confirms Medicare Part D substantially reduced out-of-pocket costs and increased access to medicines for seniors....

The Dangers of Drug Importation Pocket Card

PhRMA  |  Fact Sheet

Ensuring patients have access to needed medicines is critical, but the importation of unapproved medicines, from Canada or elsewhere in the world, poses a serious risk to public health.

Director - International Advocacy

PhRMA  |  PhRMA Career

Ability/availability to travel to international meetings to represent PhRMA and inform public policy discussions.

Medicare Plan Finder Is a Tool for Beneficiaries to Help Make Part D Plan Selections Each Year

Chartpack  |  From Our Network

Beneficiary choice of plans is a key feature of Part D’s competitive structure....

Patients Facing Access Restrictions Incur Greater Medical Spending

Chartpack  |  From Our Network

Non-elderly Medicaid patients facing formulary restrictions for antipsychotic medications were more likely to be hospitalized and had higher medical costs than patients in states without formulary restrictions....

Leading Therapy Classes in Part D

Chartpack  |  From Our Network

Ninety-two percent of Part D enrollees filled at least one prescription in 2011....

Shrinking Costs of Part D

Chartpack  |  From Our Network

Estimated 2014 costs for Part D are less than half the initial Congressional Budget Office (CBO) projections....

PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check

PhRMA  |  Blog Post

The campaign focuses on the new era of medicine, public health and ways we can evolve our private payment and reimbursement system to be as innovative as the medicines our companies produce.

PhRMA Statement on Commissioner Scott Gottlieb’s Address to the Regulatory Affairs Professionals Society 2017 Regulatory Conference

PhRMA  |  Press Release

(September 12, 2017) – Pharmaceutical Research and Manufacturers of America (PhRMA) director, Public Affairs, Andrew Powaleny issued the following statement following U.S.

Statement on Biosimilar User Fee Act Reauthorization

PhRMA  |  Press Release

Key provisions about the BsUFA II performance goals letter: Continue to improve the efficiency of the science-based FDA review process for biosimilars; Establish dedicated staff capacity for key functions, such as facilitating scientific coordination, policy development, operations management, program governance, internal training, educational outreach, and communication; and  Help ensure the long-term sustainability of BsUFA activities through modernized time reporting and capacity planning.

Senior Director – Federal Advocacy

PhRMA  |  PhRMA Career

Requirements Bachelor’s degree in Political Science, Government Relations, Public Policy, or other related field of study;  5-7 years of direct experience working with or for the Congress and/or Federal Advocacy work; Understanding of procedures, protocols of standing committees regarding witnesses, testimony and Congressional activities, working knowledge of the Congressional process and ethics rules and regulations; Strong relationship building skills, integrity and reputation; easily builds a rapport and can persuade others Strategically anticipates potential future federal advocacy issues; Strong verbal and written communication skills; Demonstrated collaborator and team player.

How modernizing FDA regulations can benefit patients, providers and payers

PhRMA  |  Blog Post

To read PhRMA and BIO’s joint principles on communications with health care professionals and payers, go to:

New surveys find payers and providers want more data from biopharmaceutical companies

PhRMA  |  Blog Post

View the survey findings here.

VIDEO: PhRMA CEO joins CNBC’s Squawk on the Street to discuss industry campaign #GOBOLDLY

PhRMA  |  Blog Post

Ubl spoke with the anchors of CNBC’s Squawk on the Street about the biopharmaceutical industry’s new national, multi-year advertising and public affairs campaign: #GOBOLDLY.

Robert Zirkelbach

PhRMA  |  Biography

He is a graduate of Central College (IA) where he studied communications, business, and public policy.

PhRMA Launches New “Share the Savings” Campaign to Urge Payers to Share Negotiated Discounts with Patients  

PhRMA  |  Press Release

(April 6, 2017) — The Pharmaceutical Research and Manufacturers of America (PhRMA) today unveiled “Share the Savings,” a new campaign to educate the public about the lack of rebate pass-through for commercially insured patients with high deductibles and coinsurance.

Better Use of Medicines Yields Significant Health Gains and Savings on Other Services

Chartpack  |  From Our Network

Due to a growing body of evidence, in 2012 the Congressional Budget Office (CBO) began recognizing reductions in other medical expenditures associated with increased use of prescription medicines in Medicare that were not taken into account when CBO originally estimated Part D's cost....

Sources of Prescription Drug Spending in the United States

Chartpack  |  From Our Network

Together, Medicare and Medicaid account for approximately one-third of outpatient drug spending....

Contact PhRMA

PhRMA  |  From PhRMA

Public Transportation Metro Gallery Place-Chinatown (Green, Yellow & Red lines)Metro Center: (Blue, Orange and Red lines) Airport Ronald Reagan Washington National Airport [DCA] 4 miles awayDulles International Airport [IAD] 27 miles away

Reductions in Hospital Admissions Following Part D Implementation

Chartpack  |  From Our Network

Researchers found that gaining Medicare Part D prescription drug coverage was tied to a reduction in hospital admissions....

Average Beneficiary Premiums Are Far Below Original Estimates

Chartpack  |  From Our Network

Modest increases in premiums are going to make medications more affordable to Medicare beneficiaries, according to the Centers for Medicare & Medicaid Services....

Gaining Drug Coverage Reduced Other Medical Spending

Chartpack  |  From Our Network

The Medicare drug benefit increased access to medicines for those previously without drug coverage...

The US Prescription Drug Lifecycle Promotes Innovation and Affordability

Chartpack  |  From Our Network

Since 2006, the daily cost for the top-10 therapy areas in Medicare Part D has fallen by nearly half....

You have reviewed the first 150 results out of 883. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next